Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,193.83, giving the company a market capitalization of 1.12T. It carries a P/E multiple of 41.92 and pays a dividend yield of 0.52%.
On 2026-08-26, Eli Lilly(LLY) stock traded between a low of $1,180.01 and a high of $1,239.30. Shares are currently priced at $1,193.83, which is +1.2% above the low and -3.7% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.18M, compared to an average daily volume of 2.39M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Eli Lilly and Co. (NYSE:LLY) shares are trading lower Wednesday, pulling back after the stock notched an all-time high just last week, even as the company separ...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. (LLY) has launched a Phase 1 trial titled “A Placebo-Control...
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s (LLY) new blood test that helps to identify signs of Alzheimer’s disease in people aged 55...
Analyst ratings
82%
of 33 ratingsMore LLY News
Key Points Obesity drugs like Mounjaro and Zepbound could help the drugmaker power ahead for years. Its Alzheimer’s drug Kisunla and broad pipeline add anothe...
The Fidelity MSCI Health Care Index ETF (FHLC +0.47%) provides broad, low-cost exposure to the entire healthcare sector, whereas the VanEck Pharmaceutical ETF (...
Eli Lilly (LLY) announced results from a real-world study of adults over 55 with overweight or obesity, which found that staying on Zepbound for weight manageme...
Eli Lilly stock has logged very strong gains over the past few years, yet the latest valuation checks send a mixed message about where fair value may sit. The i...
Beverage giant PepsiCo (PEP) is declining to cover the cost of weight-loss drugs for its employees. The news is a perceived blow to Eli Lilly (LLY) and has the...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) has completed a Phase 1 study titled “A Phase 1, O...
Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush By Vandita Jadeja Published Aug 25, 10:30AM EDT Quick Read LLY posted 48% revenue grow...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.